Skip to main content

Page of 2 next disabled
and
  1. No Access

    Chapter

    Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction

    Adopting novel biomarkers for use in prostate cancer screening requires rigorous scientific evaluation. The predictive accuracy of the markers must be quantified and compared with other potential markers. In t...

    Yingye Zheng, Donna P. Ankerst in Prostate Cancer Screening (2009)

  2. No Access

    Chapter

    The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening

    When considering the application of a screening test for any disease, it is extremely important to understand how the performance characteristics of a test will affect its usefulness to a patient as well as to...

    JR Ian M. Thompson MD, Donna P. Ankerst in Prostate Cancer Screening (2009)

  3. No Access

    Article

    Sequestosome 1 (SQSTM1) Mutations in Paget’s Disease of Bone from the United States

    Paget’s disease of bone (PDB) is a localized bone disease characterized by excessive bone resorption due to overactive osteoclasts. Seven genetic loci (PDB1-PDB7) have been reported for late-onset PDB. PDB3 is...

    Emily C. Rhodes, Teresa L. Johnson-Pais in Calcified Tissue International (2008)

  4. Article

    Open Access

    Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT

    Cryopreservation of PBMC and/or overnight ship** of samples are required for many clinical trials, despite their potentially adverse effects upon immune monitoring assays such as MHC-peptide tetramer stainin...

    Holden T Maecker, James Moon, Sonny Bhatia, Smita A Ghanekar in BMC Immunology (2005)

Page of 2 next disabled